Jun 3, 2025

Featuring perspectives from Dr Daniel George, Dr Leonard G Gomella and Dr Evan Y Yu, moderated by Dr George, including the following topics:

• Introduction (0:00)
• Current Treatment Landscape for Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) — Dr Gomella (3:42)
• Clinical Implications of and Appropriate Strategies...

May 15, 2025

Featuring perspectives from Dr Emmanuel S Antonarakis and Prof Karim Fizazi, including the following topics:

• Introduction: Quality of Life (0:00)
• PARP Inhibition (PARPi) (7:15)
• M0 Disease (23:18)
• Metastatic Hormone-Sensitive Prostate Cancer (34:33)
• Radiopharmaceuticals (46:16)
• Other Novel Investigational Approaches for...

May 14, 2025

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Prostate Cancer | Faculty Presentation 2: Other Available and Emerging Therapeutic Approaches — Emmanuel S Antonarakis, MD

CME information and select...

May 13, 2025

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Prostate Cancer | Faculty Presentation 1: Optimizing the Role of Hormonal Therapy in the Care of Patients with Prostate Cancer (PC) — Professor Karim Fizazi, MD, PhD

CME information and select...

May 8, 2025

Featuring perspectives from Dr Rahul Aggarwal, Ms Monica Averia, Ms Kathleen D Burns and Dr William K Oh, including the following topics:

• Introduction: Overview of Prostate Cancer (0:00)
• Recent Advances in the Treatment of Nonmetastatic Prostate Cancer (8:36)
• Treatment Approaches for Metastatic Hormone-Sensitive...